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Abstract
Staphylococcus aureus particularly methicillin-resistant Staphylococcus aureus (MRSA) strains 
is one of the major causes of community and hospital-acquired bacterial infections. They 
are also becoming increasingly multidrug resistant and recently developed resistance to 
vancomycin, which has been used successfully to treat MRSA for many years. In vitro 
determination of drug resistance patterns of S. aureus is critical for the selection of effective 
drugs for the treatment of staphylococci infections. The main aim of this review was to 
determine the prevalence of drug-resistant S. aureus strains from different clinical speci-
mens throughout the world. Various types of research study designs such as cross-sec-
tional and retrospective and laboratory techniques like Kirby Bauer, agar dilution, and E 
tests were used. The result of each study was narrated accordingly.
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1. Introduction
Staphylococcus aureus particularly methicillin-resistant Staphylococcus aureus (MRSA) strains 
is one of the major causes of community and hospital-acquired bacterial infections. They are 
also becoming increasingly multidrug resistant and recently developed resistance to vanco-
mycin, which has been used successfully to treat MRSA for many years. In vitro determina-
tion of drug resistance patterns of S. aureus is critical for the selection of effective drugs for 
the treatment of staphylococci infections. The main aim of this review was to determine the 
prevalence of drug-resistant S. aureus strains from different clinical specimens throughout 
the world. Different types of research study designs such as cross-sectional and retrospective 
and laboratory techniques like Kirby Bauer, agar dilution, and E tests were used. The result 
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of each study was narrated with respect to antimicrobial susceptibility pattern of S. aureus to 
various drugs accordingly.
A study on methicillin resistance against S. aureus in Trinidad and Tobago was conducted 
by Akpaka et al. [1]. Of 1912 S. aureus isolates recovered from different clinical samples, 
12.8% were found out to be methicillin (oxacillin) resistant. The highest (86%) of the isolates 
were obtained from wound swabs and the least from urine (0.4%) specimens. About 85% 
of methicillin-susceptible S. aureus (MSSA) were sensitive to commonly used antimicrobials 
in the country. On the other hand, all MRSA isolates were resistant to ceftriaxone, eryth-
romycin, gentamycin, and penicillin but were 100% sensitive to vancomycin, rifampin, and 
chloramphenicol.
Similar study was carried out by Orrett and Land [2] in Trinidad and Tobago. In this study, 
2430 isolates of S. aureus strains recovered from various clinical sources, from hospital and 
community practices, were analyzed. The prevalence of MRSA varied with the type of clinical 
sample. The prevalence of MRSA from surgical/burn wound was the highest (60.1%) followed 
by urine (15.5%) and pus/abscess (6.6%), respectively. The prevalence of MSSA also varied 
with the type of clinical samples. The major sources of MSSA were surgical/burn wounds, pus/
abscess, and upper respiratory tract specimens with rates of 32.9, 17.1, and 14.3%, respectively. 
Furthermore, 109 (4.5%) S. aureus strains were isolated from sputum, 201(8.3%) from blood, 
and 95(4%) from eye infection. Clinical specimens each accounting less than 3% of the total 
include the vagina, ear, and CNS. With regard to the antimicrobial susceptibility profile of the 
isolates, the greatest prevalence of resistance of MRSA was seen for erythromycin (86.7%) and 
clindamycin (75.3%). Resistance rates among MSSA were highest for ampicillin (70%).
Oxacillin-resistant and multidrug-resistant Staphylococcus aureus in Lima, Peru, was stud-
ied by Seas et al. [3]. S. aureus isolates were recovered from the blood, sterile body fluids 
(e.g., cerebrospinal fluid, peritoneal, joint, and pericardial fluids), urine, skin and soft tissue, 
lungs, abscesses, surgical wound sites, and catheters. Of 103 strains isolated, 70 (68%) were 
MRSA. In the United States, the prevalence of MRSA in skin and soft tissue infections was 
conducted by Frazee et al. [4]. Among 137 study subjects, 119 S. aureus isolates were recov-
ered of which MRSA was present in 51% of infection site cultures. Of 119 isolates 89 (75%) 
were MRSA. All MRSA strains were susceptible to trimethoprim/sulfamethoxazole, 94% to 
clindamycin, 86% to tetracycline, and 57% to levofloxacin. Similarly, results of this study 
revealed that the prevalence of MRSA was 59%. Moran et al. [5] conducted MRSA prevalence 
study in patients with skin and soft tissue infections. In this study a total of 422 patients with 
skin and soft tissue infections were enrolled. S. aureus was isolated from skin and soft tissue 
infection in 320 (76%) patients of which 249 (78%) of the S. aureus isolates were MRSA. This 
study revealed that the isolation rate of MRSA varies with respect to clinical sample. MRSA 
isolated from abscesses, purulent wounds, and cellulitis with purulent exudates accounted 
61, 53, and 47%, respectively.
The prevalence of MRSA across the European countries from 1999 to 2002 was analyzed by 
Tiemersma et al. [6]. In this study a total of 50,759 S. aureus isolates were collected from 495 
hospitals in 26 countries. The prevalence of MRSA varied from 1% in Northern Europe to 40% 
in Southern and Western Europe. The study also has shown that the prevalence of MRSA 
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increased significantly in countries such as Belgium, Germany, Ireland, the Netherlands, and 
the United Kingdom, while the prevalence of MRSA showed a decrease in Slovenia. In addi-
tion this study revealed that MRSA was more frequently isolated from men than women and 
patients with blood culture positive for MRSA were older than patients with MSSA.
Many studies on the prevalence of MRSA have been conducted in India. A total of 1426 
wound swabs were taken from 450 high-risk patients by Vidhani et al. [7] of which S. aureus 
was isolated from 188 patients (41.8%) and out of which 97 (51.6%) patients were found to be 
MRSA. A marked difference in antibiotic sensitivity pattern of MRSA and MSSA isolates was 
reported. According to the results of this study, none of the MRSA isolate was found to be 
sensitive to penicillin and amoxicillin. However, 6 (5.5%) and 12 (11%) MSSA were sensitive 
to penicillin and amoxicillin. A total of 85 (77.9%) of MSSA were sensitive to cefotaxime, while 
only 17 (21.5%) of MRSA were sensitive to this antibiotic. Sensitivity to macrolide group of 
antibiotics like erythromycin and roxithromycin was seen in 77 (70.6%) of MSSA in compari-
son to 14 (17.7%) of MRSA. Susceptibility test results of this study further showed that among 
the aminoglycosides maximum sensitivity of MSSA was seen with amikacin 74 (67.9%), while 
only 21 (26.6%) of MRSA were sensitive to the same antibiotic. A total of 53 (67%) of MRSA 
and 76 (69.7%) of MSSA were found to be sensitive to fluoroquinolone group, that is, ofloxa-
cin. All S. aureus isolates (MRSA and MSSA) were found to be uniformly sensitive to vanco-
mycin which is the drug of choice for treating infections caused by MRSA.
Another study conducted by Rajendra Goud et al. [8] revealed a prevalence 29.76% of com-
munity-associated MRSA. All community-associated MRSA were resistant to methicillin and 
penicillin, while resistance to erythromycin and vancomycin was 65 and 1.12%, respectively, 
but all MRSA isolates were sensitive to linezolid. A third study conducted by Sharma and 
Mall [9] found out that out of 200 nasal samples, S. aureus was recovered from 97 patients, 
and of these, 23 isolates were MRSA. The drug resistance patterns of MRSA isolated from 
clinical specimens, and carrier screening samples were found to be highly variable. Almost all 
the MRSA strains (91.3%) screened from nasal samples were resistant to amikacin, 86.95% to 
kanamycin and cloxacillin, 78.26% to ciprofloxacin, 56.52% to erythromycin, 52.17% to chlor-
amphenicol, and 34.78% to both tetracycline and gentamycin. The production of β-lactamase 
enzyme in MRSA was found to be 19 (82.6%). Chandrashekhar et al. [10] isolated 312 S. aureus 
strains of which 177 (56.75%) were found to be MRSA. Susceptibility profile of this study 
showed that all MRSA were resistant to penicillin, followed by erythromycin (91.5%), ampi-
cillin+ sulbactam (90.4%), amoxicillin (83.6%), norfloxacin (81.4%), cefuroxime (78.5%), and 
amikacin (25.4%). However, no strains were resistant to vancomycin. Similar study carried 
out by Kaur et al. [11] revealed that 27 out of 70 (38.6%) S. aureus isolates were MRSA.
A number of similar studies were carried out in other Asian countries. A study carried 
out in Tehran by Vahdani et al. [12] exhibited marked variation in the drug susceptibility 
of MRSA. The results of this study showed that all the 90 MRSA isolates were resistant to 
penicillin (100%), ampicillin (92%), and cefotaxime (93%). Vancomycin and chloramphenicol 
were the most effective antibiotics, and only 7 and 14% of isolates were resistant, respectively. 
Nitrofurantoin, gentamycin, amikacin, ciprofloxacin, and other cephalosporins like cefepime 
and cefazolin were better active than penicillin, ampicillin, and cefotaxime. This study showed 
that 44% of hospital-acquired MRSA strains were resistant to co-trimoxazole. Akhter et al. [13] 
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in Karachi isolated MRSA and determined the drug susceptibility of pattern of both MRSA 
and MSSA. A total of 87 strains of S. aureus were recovered from various clinical samples by 
the authors. Of these, 66 (75.8%) strains were recovered from various swabs and 21 (24.13%) 
from blood. Of the isolates 20 (22.9%) were methicillin resistant. In this group high resistance 
was found to cloxacillin (100%), co-trimoxazole (95%), erythromycin (70%), and gentamicin 
(55%), and low resistance was observed to ciprofloxacin (30%). In MSSA 0% resistance was 
seen to ciprofloxacin and chloromycetin, and high resistance was found to co-trimoxazole 
(98.5%) and penicillin (73.13%). Both MRSA and MSSA were 100% sensitive to vancomycin. A 
total of 139 MRSA were isolated by Kaleem et al. [14] in Pakistan. Of this most of the MRSA 
were isolated from pus samples. As far as their drug susceptibility is considered, all of the 
isolated MRSA were found to be susceptible to vancomycin and linezolid. Furthermore, 130 
isolates (94%) were susceptible to teicoplanin and minocycline, whereas 93% of isolates were 
sensitive to chloramphenicol and 91% were sensitive to tetracycline. Only 38 and 22% of the 
isolates were susceptible to fluoroquinolones and macrolides, respectively.
A good number of research work on the prevalence, rate of isolation, and drug susceptibility 
profile of MRSA have been carried out in Africa. A study carried out by Ojulong et al. [15] 
investigated 188 pus swabs collected from patients with surgical site infections. Out of 54 
(28.7%) S. aureus isolates, 17 (31.5%) were found out to be MRSA. Resistance rates of MRSA 
were found out to be 88.2% for trimethoprim-sulfamethoxazole, 88.2% for erythromycin, 
58.8% for gentamycin, 70.6% for ciprofloxacin, and 88.2% for chloramphenicol, and all MRSA 
isolates were found to be sensitive to vancomycin and clindamycin. A study carried out in 
Sudan by Alamin et al. [16] recovered 85 S. aureus strains of which 21 (24%) were isolated from 
nasal cavity, 26 (31%) from skin surface, 22 (26%) from wounds, and 16 (19%) from the throat. 
Out of 85 isolates, 25 were found out to be MRSA.
Okwu et al. [17] in Nigeria examined 120 samples taken from the nose. Of these 22 (18.3%) were 
found to be positive for S. aureus, and 13 (10.8%) of the isolates were oxacillin resistant. Their 
studies also depicted that seven (11.7%) MRSA strains were obtained from females, while six 
(10%) strains were from males. Also, 12 (19.4%) S. aureus and 7 (11.3%) MRSA were isolated 
from the age group of 9–14 years, while 10 (17.3%) isolated of which 6 (10.3%) were MRSA iso-
lated the age groups of 3–8 years. Furthermore, the isolates were resistant to ampicillin (100%), 
cloxacillin (100%), penicillin (100%), tetracycline (82%), chloramphenicol (73%), erythromycin 
(68%), gentamicin (64%), streptomycin (56%), and oxacillin (55%). Another study conducted 
by Olowe et al. [18] in the same country, Nigeria, depicted that out of 67 S. aureus isolates, 
32(47.8%) were resistant to methicillin. High prevalence of MRSA, 13 (19.4%), was isolated 
from wound, while urine sample had the least, 1(1.5%). High resistance levels (87.5%) were 
detected against penicillin and tetracycline, while gentamicin and vancomycin recorded the 
least resistance levels of 62.5 and 6.3%, respectively. The starch paper analysis confirmed the 
presence of beta-lactamase production in all the isolates tested (100%). Similar study was con-
ducted to detect beta-lactamase production in the same country by Efuntoye et al. [19]; of the 
95 isolates tested. A total of 79 (83.2%) were beta-lactamase-producing strains.
In Ethiopia, a retrospective study on the prevalence of MRSA was conducted by Geyid et al. 
[20]. The results of this study showed that among 249 S. aureus isolates 75 (30.5%) were found 
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out to be MRSA, while 173 (69.5%) were MSSA. With regard to antibiotic susceptibility pat-
tern of the isolates, vancomycin and clindamycin were effective against all S. aureus isolates. 
The presence of beta-lactamase production was determined in the 355 S. aureus isolates, and 
252 (71%) were found to be beta-lactamase producers. Furthermore, 47 (62%) of the MRSA 
isolates and 140 (81%) of the MSSA isolates were beta-lactamase-positive strains. The sensi-
tivity pattern of all the S. aureus isolates against 11 common drugs indicated that the majority 
(80%) of the MRSA strains were multidrug resistant, while 4 (8%) were not resistant to any of 
the drugs tested. A total of 41 (54%) MRSA strains were both beta-lactamase producers and 
multidrug-resistant isolates. Another study carried out in Felege Hiwot Referral Hospital, 
Bahir Dar, showed that 55% of S. aureus isolates were MRSA [21].
Similarly, in a study conducted by Dilnessa et al. [22], of 1360 clinical specimens analyzed, 
S. aureus was recovered from 194 (14.3%). Rate of isolation of S. aureus with regard to clini-
cal specimens was the highest in pus 118 (55.4%). No S. aureus was isolated from CSF and 
urethral discharge. Out of 194 S. aureus isolates, 34 (17.5%) were found out to be MRSA and 
the remaining 160 (82.5%) were MSSA. A total of 98 (50.5%) S. aureus isolates were multidrug 
resistant, and the highest isolates were resistant to penicillin 187 (96.4%) and least resistant 
for clindamycin 23 (11.9%) and vancomycin 10 (5.1%). MRSA strains were 100% resistant to 
penicillin G, erythromycin, and trimethoprim-sulfamethoxazole and least resistant to vanco-
mycin 10 (29.4%). Out of 194 S. aureus isolates, 153 (79.0%) were beta-lactamase producers 
(Table 1).
Factors that could contribute to variations in the prevalence rate of MRSA and vancomycin 














Moran et al. (2006) USA 422 320 (76) 249 (78.0) 71 (22.0) — —
Ojulong et al. (2009) Uganda 188 54 (28.7) 17 (31.5) 37 (68.5) 0 —
Sharma and Mall 
(2011)
India 200 97 (48.5) 23 (23.7) 74 (76.3) — —
Okwu et al. (2012) Nigeria 120 22 (18.3) 13 (59.1) 9 (40.9) — 100
Akpaka et al. (2006) Spain — 1912 244 (12.8) 1668 (87.2) 0 —
Geyid et al. (1991) Ethiopia 17,142 249 (1.4) 76 (30.5) 173 (69.5) 0 80
Dilnessa et al. (2016) Ethiopia 1360 194 (14.3) 34 (17.5) 160 (82.5) 5.1 50.5
Olowe et al. (2012) Nigeria — 67 32 (47.8) 35 (52.2) 6.3 100
Vidhani et al. (2000) India 450 188 (41.7) 97 (51.6) 91 (48.4) — 79.5
Alamin et al. (2013) Malaysia — 85 25 (29.4) 60 (70.6) 8 —
MRSA, Methicillin-resistant S. aureus; MSSA, methicillin-susceptible S. aureus; MDRSA, multidrug-resistant S. aureus; 
VRSA, vancomycin-resistant S. aureus
Table 1. Comparison of different literatures with respect to methicillin- and vancomycin-resistant pattern of Staphylococcus 
aureus in different countries.
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and sample type, and the lab procedures employed can be mentioned. The isolates were mul-
tidrug resistant to several combinations of the tested antibiotics. According to Magiorakos 
et al. [23], MDR is defined as non-susceptibility to at least one agent in three or more antimi-
crobial categories. Over all drugs such as gentamicin, amoxicillin-clavulanate, clindamycin, 
cefuroxime, vancomycin, and cephalothin had relatively lower resistance.
2. Conclusion
The prevalence of S. aureus and MRSA varies appreciably based on the type of clinical sam-
ples. Pus is the main source of S. aureus and MRSA than other samples in hospital settings. 
The prevalence of MRSA stains obtained from different studies varies based on geographi-
cal location. Many MRSA strains were multidrug resistant, and a good number of the iso-
lates were also resistant to vancomycin, the drug of choice for treating multidrug-resistant 
MRSA infections. Reducing this burden by good infection control practices such as strict 
hand washing, by identifying MRSA carriers, and treating them, the prudent use of antimi-
crobial agents is recommended. Beta-lactamase production plays a great role for acquisition 
of MRSA. Physicians should prescribe drugs after the sensitivity pattern of the microbe is 
known. Additionally, large-scale longitudinal study is needed to determine CA-MRSA and 
HA-MRSA. Further phenotypic and genotypic studies are needed to establish and clarify the 
genetic mechanism behind susceptibilities to antibiotics.
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